Italian laser manufacturer's medical aesthetics business accelerates, outpacing overall company growth.
EL.En., the Italian laser manufacturer, reported that its medical segment drove 9% revenue growth in the first half of 2026, with higher margins offsetting slower growth in other divisions. The company confirmed full-year 2026 guidance, signaling confidence in sustained momentum.
EL.En. owns DEKA (RF and laser platforms), Quanta System (Nd:YAG and diode), and Cynosure (acquired years ago). The medical aesthetics acceleration reflects strong demand for laser and RF devices globally, particularly in Asia and emerging markets. Higher margins suggest the company is pricing power into new product launches and maintaining pricing discipline as competition intensifies.
Medical segment margins are expanding even as revenue growth accelerates.
For US medspa owners, EL.En.'s strength matters less directly than InMode or Cutera, but it signals that device manufacturers globally are seeing robust demand and can sustain R&D investment. That competition keeps innovation moving and pricing honest.
Source: original report ↗
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/mo
Join the owners who run ahead of the industry. Cancel anytime, one click.
